Sterile Injectable Drug Recall: oxyTOCIN in Lactated Ringer's IV Bags
Central Admixture Pharmacy Services is recalling 1,996 bags of oxyTOCIN in Lactated Ringer's IV bags because the company cannot assure the products are sterile. The firm lacks validation data for its sanitization procedures.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a sterile injectable drug with no reported illnesses or injuries. The hazard—contamination from inadequate sterilization validation—is a significant risk for intravenous solutions but remains theoretical until actual contamination is confirmed.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling 1,996 bags of oxyTOCIN 30 units added to Lactated Ringer's 500 mL IV bags due to lack of assurance of sterility. The recall affects specific lot numbers: 36-260043, 36-260039 (exp. 9/8/2023), 36-262220 (exp. 9/10/2023), and 36-262526, 36-262525, 36-262524 (exp. 9/14/2023).
The reason for the recall is that the company lacked validation data to ensure that their sanitization cycles were adequate to achieve the required level of sterility. Without this validation, there is no assurance that the intravenous solutions were properly sterilized and are safe for patient use.
The recalled IV bags were distributed nationwide in the United States. Patients receiving these products should consult with their healthcare provider. Healthcare facilities should quarantine affected bags and contact Central Admixture Pharmacy Services or the FDA for instructions on proper handling and replacement.
The recalled product
- Product
- oxyTOCIN 30 units added to Lactated Ringer's 500 mL, IV Bag, Rx only, Cental Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-6039-1
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug — IV Admixture
- Hazard
- sterilization-failure
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Lot# 36-260043
- 36-260039
- Exp 9/8/2023
- 36-262220
- Exp 9/10/2023
- 36-262526
- 36-262525
- 36-262524
- Exp 9/14/2023.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27